- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.12. | BIOSECURE Act set for Congress vote after inclusion in annual defence bill | ||
| 09.12. | Mirum to buy Bluejay for up to $820m in rare liver disease push | ||
| 09.12. | Pfizer gains another obesity asset with $2bn deal for YaoPharma's GLP-1RA | ||
| 09.12. | EC approves Roche's Gazyva to treat active lupus nephritis | ||
| 09.12. | Inductive Bio gains $21m ARPA-H funds for drug prediction models | ||
| 08.12. | Medical bodies sound alarm over US hepatitis B vaccine vote | ||
| 08.12. | Viatris signs agreements with Biocon on $815m stake sale | ||
| 08.12. | Agilent and Monash University Malaysia to set up biodiscovery hub | ||
| 05.12. | CDC panel votes to revoke newborn hepatitis B vaccine recommendation | ||
| 05.12. | Crescent and Kelun-Biotech swap cancer asset rights in double deal | ||
| 05.12. | Denali makes $275m funding agreement with Royalty Pharma | ||
| 05.12. | Takeda and Innovent fulfil close conditions for ADC and IO therapies | ||
| 04.12. | Former FDA commissioners unite to condemn US vaccine proposals | ||
| 04.12. | FDA appoints Tracy Beth Høeg as fifth CDER head this year | ||
| 04.12. | Formosa and Rxilient sign licensing agreement for APP13007 | ||
| 04.12. | FDA approves Eli Lilly's Jaypirca in relapsed or refractory CLL/SLL | ||
| 03.12. | Richard Padzur to leave FDA following recent CDER leadership shift | ||
| 03.12. | AGC Biologics to expand cell line development with ATUM partnership | ||
| 03.12. | Citizen Health and UCB collaborate for epilepsy drug development | ||
| 02.12. | FDA steps back from preclinical primate testing amid wider regulatory shift | ||
| 02.12. | WHO backs use of GLP-1RAs for weight loss despite shortage warning | ||
| 02.12. | House passes bill that reauthorises the FDA's paediatric priority voucher pathway | ||
| 02.12. | Solid Biosciences' SGT-212 gains FDA rare paediatric disease status | ||
| 02.12. | Lotus submits NDA for VIZZ in South Korea to treat presbyopia | ||
| 01.12. | UK and US strike "landmark" zero-tariff pharma deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .